Koichi Goto

33PUBLICATIONS
316CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsAutoimmunityMicrobial genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (33)

|Sep 09, 2026
Osimertinib After Definitive Chemoradiotherapy in Unresectable Stage III EGFR-Mutated NSCLC: Subsequent Treatments and PPO From the Phase III LAURA Study.

|May 06, 2026
Epidemiology and Real-World Outcomes in Patients with Human Epidermal Growth Factor Receptor 2 (HER2)-Mutant Non-small Cell Lung Cancer by Region: A Targeted Literature Review.

|Feb 04, 2026
Repotrectinib in NTRK fusion-positive advanced solid tumors: a phase 1/2 trial.

Benjamin Besse, Jessica J Lin, Lyudmila Bazhenova

|Feb 04, 2026
Concurrent Pituitary and Thyroid Immune-Related Adverse Events after Immune Checkpoint Inhibitors Associated with HLA-DR15-Related Haplotypes.

Tomoko Kobayashi, Shintaro Iwama, Eri Sugiyama

|Dec 01, 2025
Amivantamab Plus Lazertinib in Atypical EGFR-Mutated Advanced Non-Small Cell Lung Cancer: Results From CHRYSALIS-2.

Pascale Tomasini, Yongsheng Wang, Yongsheng Li

|Oct 15, 2025
Sevabertinib, a Reversible HER2 Inhibitor with Activity in Lung Cancer.

Franziska Siegel, Stephan Siegel, Kristýna Kotýnková

Pageof 6

Frequent Collaborators

5 joint publications

Alexander Drilon

4 joint publications

Susumu S Kobayashi

4 joint publications

Benjamin Besse

4 joint publications

Benjamin J Solomon